Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,090 | 15,364 | 50,438 | 48,609 | 56,911 |
| Marketable Securities | 32,932 | 69,488 | 71,308 | 34,929 | 54,999 |
| Receivables | 51,448 | 52,049 | 42,188 | 40,303 | 41,103 |
| Inventories | 52,059 | 54,573 | 52,239 | 61,318 | 56,470 |
| TOTAL | $178,159 | $205,435 | $223,804 | $194,209 | $222,593 |
| Non-Current Assets | |||||
| PPE Net | 21,512 | 22,160 | 22,619 | 23,468 | 23,858 |
| Other Non-Current Assets | 21,207 | 23,356 | 25,529 | 26,288 | 27,272 |
| TOTAL | $42,719 | $45,516 | $48,148 | $49,756 | $51,130 |
| Total Assets | $220,878 | $250,951 | $271,952 | $243,965 | $273,723 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,065 | 3,225 | 6,547 | 13,804 | 8,226 |
| Accrued Expenses | 30,783 | 37,884 | 52,006 | 59,993 | 82,291 |
| TOTAL | $77,900 | $82,355 | $93,876 | $109,498 | $93,001 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 154,407 | 155,024 | 155,626 | 156,203 | 156,764 |
| TOTAL | $154,407 | $155,024 | $155,626 | $156,203 | $156,764 |
| Total Liabilities | $232,307 | $237,379 | $249,502 | $265,701 | $249,765 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 119,715 | 119,259 | 118,888 | 102,632 | 102,480 |
| Common Shares | 1,193 | 1,191 | 1,188 | 1,025 | 1,021 |
| Retained earnings | -1,828,223 | -1,795,455 | -1,775,586 | -1,733,678 | -1,677,319 |
| Other shareholders' equity | 9 | -19 | -57 | -11 | -8 |
| TOTAL | $-11,429 | $13,572 | $22,450 | $-21,736 | $23,958 |
| Total Liabilities And Equity | $220,878 | $250,951 | $271,952 | $243,965 | $273,723 |